Lung alveolar regeneration occurs in adult human lungs as a result of proliferation, differentiation and alveolar morphogenesis of stem cells. It is increasingly being believed that bronchial epithelial cells (BECs) have a potential as stem cells, because they are potent to differentiate into multiple central and peripheral lung cell types in three-dimensional (3D) cultures, and they develop multiple foci with well-differentiated histogenesis after transformed into neoplastic cells. In this study, we investigated morphogenic abilities of HBE135 human BECs immortalized by E6/E7 oncogene in 3D cultures. When HBE135 cells were cultured alone or co-cultured with endothelial cells, the cells formed spherical colonies without branching. However, in co-culture with lung fibroblast MRC-9 cells, HBE135 cells formed colonies with bronchioalveolar-like complex branching, suggesting that MRC-9-derived soluble factor(s) are responsible for the branching formation. MRC-9 cells, not endothelial cells, were found to highly express hepatocyte growth factor (HGF), a soluble molecule involved in liver and kidney regeneration. An anti-HGF neutralizing antibody severely suppressed the complex branching formation, but addition of HGF could not sufficiently compensate the morphogenic effects of MRC-9 cells, suggesting that MCR-9-derived HGF was necessary but insufficient for the bronchioalveolar structure formation. Immunohistochemistry revealed that Met, a cognate receptor for HGF, was highly expressed and phosphorylated in neoplastic BECs from lung adenocarcinomas with well-differentiated, not poorly differentiated, histogenesis. These results are consistent with the notion that BECs have an aspect of stem cells. This aspect appears to become manifest through HGF-Met signalling pathway activation.
Introduction
Lung cells are generally controlled in a strict spatiotemporal fashion by several soluble factors for proper organ development [1] . Human normal lungs have the capability to initiate repair and regeneration following any insult and involve cell proliferation, differentiation and morphogenesis, but the detailed mechanisms are largely unknown. Importantly, a recent report indicates that an adult human lung can regrow as demonstrated by an increase in vital capacity, enlargement of the remaining left lung and increased alveolar numbers in a patient who underwent right-sided pneumonectomy [2] . Cell turnover is normally slow in the alveolar region of the adult lung. However, after experimental injuries that damage and kill alveolar cells and/or expose them to oxidative stress, there is rapid proliferation of the surviving cells and activation of repair mechanisms. Upon failure of these processes, the pathological response varies, from emphysema to extensive interstitial fibrosis. To develop strategies for regeneration of the adult lung, we need to deepen our understanding of normal lung development and growth, and identify active developmental signalling systems that might be promising targets for therapeutic approaches.
Multipotent progenitor cells exist within the adult murine lung, which are postulated to give rise to all of the stem/progenitor cells [3] . There is now overwhelming evidence that basal cells are multipotent stem cells in the tracheobronchial region, which can both self-renew and give rise to ciliated and secretory lineages during post-natal growth, a steady-state and repair following damage to the epithelium. In vitro culture techniques including air-liquid interface and threedimensional (3D) clonal cultures enable analysis of the potential of single cells to self-renew and differentiate into ciliated and secretory cells [4, 5] . Moreover, human bronchial epithelial cells (BECs) display characteristics of multipotent stem cells of the lung [6] . When cultured in 3D systems, subtle changes in the microenvironment result in unique responses including the ability of human BECs to differentiate into multiple central and peripheral lung cell types. Therefore, the adult human lung contains a multipotent progenitor cell type with a differentiation potential that is primarily dictated by the microenvironment. Interestingly, human BECs often retain their morphogenic ability after they are transformed into neoplastic cells, as demonstrated by the fact that the resulting tumours generally have various histological components, each of which is highly morphogenic, and thereby are diagnosed as adenocarcinoma mixed subtypes [7] . Although molecular mechanisms for lung adenocarcinoma histogenesis have not yet been studied intensively, this morphogenic ability displayed by neoplastic epithelial cells may reflect the nature of human BECs as stem cells.
Hepatocyte growth factor (HGF) acts as a key regulator in various biological events including liver and kidney regeneration, suggesting that HGF has a morphogenic action [8] . In fact, when kidney epithelial Madin Darby Canine Kidney (MDCK) cells are grown in collagen gels containing HGF, they form branching tubules instead of spherical cysts [9] . HGF is also suggested to contribute to lung regeneration. Plasma and local HGF levels increase in response to lung injury under pathological conditions, and HGF exerts mitogenic and anti-apoptotic effects on lung epithelial cells [10] . We previously suggested that HGF might act as a potent multifunctional pulmotropic factor that induces the formation of alveolar networks from destroyed alveolar cells in injured lung tissues [11, 12] . Although selective deletion of the c-met gene encoding a cognate receptor for HGF in respiratory epithelium leads to malformation of alveolar septae [13] , it remains elusive whether HGF can contribute to bronchioalveolar morphogenesis during lung regeneration.
HBE135-E6/E7 (here, called shortly HBE135) cells are a human BEC line immortalized by E6/E7 oncogene but not tumourigenic, and have not been shown to display any morphogenic characteristics of stem cells [14, 15] . In the present study, we first examined morphogenic potentials of HBE135 cells in 3D cultures, and found that the cells were able to form bronchioalveolar structures in the co-presence of lung fibroblasts. Next, we examined roles of the fibroblasts, and found that fibroblast-derived HGF was necessary for HBE135 cells to form bronchioalveolar structures. Finally, we examined the relevance for this action of HGF in an in vivo setting. Immunohistochemistry provided evidence that signalling pathways mediated by HGF and its receptor Met were activated in well-differentiated adenocarcinomas where neoplastic BECs were highly morphogenic. These results not only provide new evidence that BECs have an aspect of stem cells but also suggest that induction of this aspect largely depends upon HGF-Met signalling pathway activation.
Materials and methods

Cell culture
HBE135 cells were obtained from the American Type Culture Collection (Manassas, VA, USA). The cells were cultured as manufacturer's instruction. Human umbilical vein endothelial cells (HUVECs) and human microvascular endothelial cells (HMVECs) were purchased from Lonza (Allendale, NJ, USA) and grown in MCDB131 medium supplemented with 5% foetal bovine serum, 2 mM L-glutamine and 20 ng/ml basic fibroblast growth factor (FGF). MRC-9 cells (human lung fibroblasts) and SF4-1 cells (human skin fibroblasts) were cultured in DMEM supplemented with 10% foetal bovine serum.
For 3D culture experiments, we used growth factor-reduced rBM (Matrigel; BD Biosciences, Bedford, MA, USA). Cells were mixed with 100 or 50 ll Matrigel in its liquid state, plated onto 8-or 16-well chamber slides respectively, and allowed to gelatinize at 37°C for an hour before adding 1 ml of culture medium. For culture experiments, each cell was seeded into the Matrigel to ensure clonal growth and reduces the aggregation of epithelial cells. Afterwards, the medium was changed every 3 days. A spherical colony was defined as a single sphere. A budding colony was defined as that with multiple spheres. A branching colony was defined as that with spherical parts and their ramification parts. A complex branching colony was defined as that with some branching parts. We counted the total and branching colonies one by one under a phase-contrast microscope. We evaluated the total colonies in eight-well dishes for each experiment.
Immunofluorescence analysis
Three-dimensional cultures were fixed with ice-cold 4% paraformaldehyde in PBS at 4°C for 30 min. After permeabilization with 0.3% Triton X-100 in PBS for 10 min., the cells were blocked with 5% normal goat serum in PBS for 1 hr at room temperature. Then, the cells were incubated with primary anti-E-cadherin (36/E-cadherin; BD Biosciences, San Jose, CA, USA) and anti-surfactant protein-C pro-peptide (pro-SP-C; AB3786; Chemicon International, Temecula, CA, USA) and anti-vimentin (Clone V9; DAKO, Glostrup, Denmark) antibodies at 4°C overnight. After washing with PBS, the cells were incubated with Alexa 488-conjugated IgG (1:600; Invitrogen, Carlsbad, CA, USA) as secondary antibodies and the nuclear dye propidium iodide for 30 min. at room temperature, and observed as described previously [16] . For a 5-bromo-2 0 -deoxyuridine (BrdU) assay, HBE135 cell colonies cultured for 9 days were incubated for a further 3 days with 10 lM BrdU (Nacalai Tesque, Kyoto, Japan). The colonies were fixed in 4% paraformaldehyde, and BrdU incorporation was assayed by immunofluorescence using an anti-BrdU antibody (OBT0030; AbD Serotec, Oxford, UK).
Western blot analysis
Cells were lysed on ice with lysis buffer [50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 5 mM EDTA, protease inhibitor cocktail, 2 mM Na 3 VO 4 and 50 mM NaF]. The lysates were immunoblotted as described previously [16] . Anti-phospho-Met (1234/1235) IgG [D26; Cell Signaling Technology (CST), Beverly, MA, USA], anti-Met IgG (C-12; Santa Cruz Biotechnology, Dallas, TX, USA), anti-phospho-ERK1/2 IgG (E10; CST), anti-ERK1/2 IgG (137F5; CST), anti-phospho-AKT IgG (#9271; CST) and anti-AKT IgG (#9272; CST) antibodies were used respectively.
Quantitative RT-PCR
Total RNA was extracted from cells using Trizol (Invitrogen). The quantitative RT-PCR was performed as described previously [16] . Expression was normalized to GAPDH mRNA levels. The specific primers used in this study are described in Table S1 .
Immunohistochemical analysis of human lung cancer specimens
Human lung cancer specimens (mixed subtype) were obtained from patients diagnosed with lung cancer, who underwent tumour removal surgery at Kinki University Hospital (Osakasayama, Osaka, Japan). Tumour specimens were fixed with 10% buffered formalin, embedded in paraffin and cut into 4-lm sections. The sections were subjected to immunohistochemical staining for Met (C12; Santa Cruz Biotechnology) and phosphoMet (Tyr1234/1235, D26; CST). The Ethics Committee of Kinki University approved the experimental protocol and waived the need for written informed consent (24-071). Met immunoreactivities were evaluated as follows in accordance with the methods with slight modification [17] : 0, complete absence of staining or only focal weak staining; 1+, weak to moderate staining in less than 40% of cancer cells; 2+, weak to moderate staining in at least 40% of cancer cells; 3+, strong staining in at least 10% of cancer cells, among the species with weak to moderate staining in at least 40% of cancer cells. Weak to moderate staining was defined as staining similar to or weaker than that of normal alveolar epithelium; strong staining was defined as staining clearly more intense than that of normal alveolar epithelium. The specimens graded as Met high (2+ or 3+) were positive and counted in well or poorly differentiated cancers. Immunoreactivities for phospho-Met were evaluated as either positive or negative, with a cut-off value of 5% of positively stained cancer cells [17] .
Statistical analysis
The Student's t-test was performed to evaluate the significant differences in number of colonies. The chi-squared test was used to assess the significant differences in histological positivity of Met and phosphoMet expression in lung adenocarcinoma.
Results
Mesenchymal cells play various roles in branching morphogenesis of airway epithelial cells
Franzd ottir et al. reported that the human BEC line VA-10 forms polarized spherical colonies when grown in 3D culture [18] . We first cultured HBE135 cells alone in rBM at the same concentration (333 cells per 100 ll rBM), but the HBE135 cells did not form colonies (Fig. 1A) . However, when cultured at a high cell density (3330 cells per 100 ll rBM), HBE135 cells formed spherical colonies (Fig. 1A ), although these colonies were not accompanied by a branching structure. VA10 cells form a branching structure in rBM when co-cultured with HUVECs [18] , but we did not observe branching colonies of HBE135 cells in co-culture with HUVECs (Fig. 1B) . We thus investigated whether other mesenchymal cell types affect epithelial branching morphogenesis. Human microvascular endothelial cells, human skin fibroblasts (SF4-1 cells) and human lung fibroblasts (MRC-9 cells) were also co-cultured with HBE135 cells. A total of 333 cells of HBE135 were co-cultured with mesenchymal cells at 3 9 10 3 cells/ ml in Matrigel respectively. All of the examined mesenchymal cell types had a similar potential to induce formation of epithelial colonies in 3D culture (Fig. 1B) . HBE135 cells formed colonies in co-culture with endothelial cells (HUVECs and HMVECs), which exhibited mostly spherical or budding morphology but not branching (Fig. 1C) . In contrast, MRC-9 cells induced a complex branching structure of HBE135 cells (Fig. 1C) . Some colonies were branching in co-culture with SF4-1 cells. However, in co-culture with MRC-9 cells, 83.3 AE 7.6% of the colonies showed complex branching (Fig. 1D ). These mesenchymal cell types cultured alone in rBM showed no remarkable changes (e.g. proliferation) for the experimental period (data not shown). Therefore, MRC-9 cells underwent morphogenesis to form a bronchioalveolar structure of HBE135 cells in 3D culture.
Characterization of co-culture conditions with lung fibroblasts and the bronchioalveolar structure of HBE135 cells by immunofluorescence
To examine branching morphogenesis in vitro, we analysed the branching process of HBE135 cells in co-culture with MRC-9 cells. Early colonies were observed after 6 days of culture, and the branching structure became gradually more complex by 12 days (Fig. 2A ). These bronchioalveolar structures had grown by 20 days (Fig. 2A) . Further culture of the colonies did not result in any characteristic formations. To investigate whether this morphogenic activity was induced by cytokines released from fibroblasts, HBE135 cells were suspended in rBM on top of a preformed gel layer containing MRC-9 cells. A cell-free gel layer was interposed between the two layers of HBE135 and MRC-9 cells to avoid contact of the two layers. As a result, HBE135 cells exhibited branching morphogenesis in the upper layer (Fig. 2B) . We did not observe movement of the MRC-9 cells in the lower layer to the upper layer. Subsequently, HBE135 cells were incubated in conditioned medium from cultures with preformed complex branching structures. A small number of colonies were formed under this condition (3.2 AE 0.7 colonies/100 ll rBM). These colonies had a symptom of branching, but were not equivalent to those under the co-culture condition (Fig. 2C) .
To characterize the complex branching, we first identified the proliferating cells in the branching structure by immunofluorescence. We found BrdU-positive cells in various regions of the complex branching structure (Fig. 3A) . We next examined the expression of cell markers in the branching structures. As an epithelial cell marker, E-cadherin was stained at 12 days of culture. E-cadherin was clearly seen at plasma membrane in the branching structure, especially at the distal area ( Fig. 3B and Fig. S1 ). Furthermore, expression of pro-SP-C, a marker of ATII cells, was observed in the branching structure (Fig. 3C) . We also examined aquaporin-5 (AQP-5), an ATI cell-specific protein, but did not observe its expression in the branching structure (data not shown). Furthermore, we confirmed that the branching structure did not express vimentin as a mesenchymal marker (Fig. 4D) . The Met in this branching structure of HBE135 cells was not phosphorylated under 3D culture (Fig. S2A) . It is possible that HGF-Met signalling is the early/initiation event for morphogen, and that epidermal growth factor (EGF) and/or other factors are involved in the middle or late events. On the other hand, Met phosphorylation was reduced after long-time exposure of HGF in HBE135 cells under monolayer culture (Fig. S2B) , and thus, Met phosphorylation might be inhibited by negative feedback mechanisms.
HGF is highly expressed in MRC-9 cells and has no mitogenic effects on HBE135 cells
To identify the soluble factors responsible for the complex branching of MRC-9 cells, we investigated the mRNA levels of growth factors that have been reported to accelerate alveolarization. FGF1 and VEGF-A mRNA expression in SF4-1 cells were higher than that in MRC-9 cells, and heparin-binding EGF (HB-EGF) mRNA expression was higher in HUVECs (Table 1) . However, HGF expression was dramatically higher in MRC-9 cells compared with that in the other mesenchymal cell types. Thus, HGF might play important roles in the bronchioalveolar formation. To confirm whether MRC-9 cells highly express HGF protein, 24-hr conditioned media of the mesenchymal cells were analysed by ELISA. Although HGF protein was not found in the conditioned media of HUVECs and HMVECs, 15.1 AE 5.0 ng/ml HGF protein was detected in the culture medium of MRC-9 cells. SF4-1 cells secreted 1.34 AE 0.65 ng/ml HGF in 24 hrs of culture. We also examined the mRNA expression of another cytokine FGF10, which is dynamically localized in the mesenchyme surrounding prospective epithelial buds and has been shown in vitro to act as a chemoattractant for epithelial cells [19] [20] [21] . However, we did not detect FGF10 mRNA in MRC-9 cells.
HGF is required but insufficient for the formation of bronchioalveolar-like structures
We found that HBE135 cells expressed reactive Met, a receptor for HGF, by immunoblotting (Fig. 4A) , and HGF treatment induced ERK1/ 2 ( Fig. 4B) and AKT (Fig. 4C ) phosphorylation in HBE135 cells under monolayer culture. HBE135 cells could thus respond to HGF. However, HGF had no effect on the proliferation of HBE135 cells (Fig. 4D) .
Next, to examine the role of the HGF-Met pathway in the branching formation of HBE135 cells, we used a neutralizing anti-HGF antibody in 3D culture. In preliminary experiments, we confirmed blockade of HGF signalling by the anti-HGF antibody at 10 lg/ml. The anti-HGF antibody was added at the beginning of HBE135/MRC-9 cell co-cultures and could not prevent the colony formation (normal IgG: 43.6 AE 5.5 colonies versus anti-HGF IgG: 38.2 AE 4.4 colonies; Fig. 5A ). However, the anti-HGF antibody inhibited the complex branching formation in 3D culture (Fig. 5B) . Complex branching was formed by 75.6% of colonies in cultures with normal IgG, whereas only 31.1% of colonies formed complex branching in cultures with the anti-HGF antibody (Fig. 5C ). These results indicated that the HGFMet system was important for the complex morphology in 3D cultures of HBE135 cells. Moreover, to verify whether HGF is sufficient for complex branching formation of HBE135 cells, we added recombinant human HGF (rhHGF) to 3D cultures of HBE135 cells alone. As shown in Figure 6A , we did not observe complex branching in these 3D cultures. We also added rhHGF to co-cultures of HBE135 cells with HUVECs and SF4-1 cells, but did not observe sufficient morphogenic activity for complex branching (Fig. 6B) . These results suggested that MRC-9 cells secrete factors other than HGF to induce complex branching formation.
Possible involvement of HGF signalling pathway in human lung tumour histogenesis
We considered that this complex branching formation was similar to lung adenocarcinoma, especially the well-differentiated subtype. The HGF-Met pathway also plays an important role in tumourigenesis by promoting cell proliferation, survival, scattering, motility, migration, invasion and metastasis [22] . To examine whether the complex branching structure was a useful model to study the molecular mechanisms of lung adenocarcinoma, we verified expression of Met in lung adenocarcinoma according to the degree of differentiation. Adenocarcinoma was selected from the mixed subtype as the histological diagnosis. As shown in Figure 7A , Met expression was found in normal ATII cells, but weak Met expression was found in other normal regions. Met expression was increased in well-differentiated cancer cells, especially in membranous regions (Fig. 7B) , and was relatively weak in poorly differentiated cancer cells (Fig. 7C) . Histological quantification analysis revealed that Met signals were detected in 15 cases out of 35 well-differentiated cancers and in 11 cases out of 35 poorly differentiated cancers, and thus, Met expression was not significantly correlated with the grade of differentiation (P = 0.32). As HGF exerts various effects via tyrosine phosphorylation (phospho-Met), we examined phospho-Met in lung adenocarcinoma. Phospho-Met was not observed in normal regions of the lung (Fig. 7D) . In contrast, phospho-Met was positive in well-differentiated cancer cells (Fig. 7E) , but phospho-Met signals were not detected in poorly differentiated cancer cells (Fig. 7F) . Furthermore, Met phosphorylation could be found in almost half (n = 16) of 35 well-differentiated cancers, but in only four tumours out of poorly differentiated cancers. This thus shows the significant increases in well-differentiated cancers (P < 0.01). Therefore, HGF-Met signalling might play important roles as a morphogen in some well-differentiated types of lung adenocarcinoma.
Discussion
In the present study, we found that HBE135 cells had a potential to form bronchioalveolar structures in 3D cultures, and that this morphogenic process largely depended upon HGF. Although HGF appeared to actually act on HBE135 cells, it did not show a mitogenic activity in these cells. HGF might perform various roles, such as induction of mitogenesis or morphogenesis, according to the target cells, and play important roles in the morphogenesis of stem cells. However, HGF alone did not induce epithelial morphogenesis of HBE135 cells in 3D culture. In addition to HGF, MRC-9 cells might secrete certain types of soluble factor(s) that are essential for the complex epithelial branching. In mesenchyme-free culture of the foetal lung, HGF alone does not induce epithelial morphogenesis, but HGF together with FGF1 or FGF7 induce more extensive epithelial branching than that observed by treatment with FGF1 or FGF7 alone [23] . SF4-1 cells highly express FGF1 and FGF7 mRNA, but recombinant HGF could not induce the complex branching structure in the coculture system using SF4-1 cells. Thus, it would be interesting to investigate the other factors secreted by MRC-9 cells, which are responsible for the complex branching structure. In the lung, an extensive pulmonary vascular network runs parallel to the airway and surrounds the intricate alveolar structure lined by respiratory epithelial cells. The close association between the two tissue compartments is essential for their functional coupling that is required for respiration. To generate alveolar structures, the vasculature and epithelium develop in a highly mutual-dependent fashion. However, HBE135 cells did not form the complex branching structure in co-culture with endothelial cells such as HUVECs and pulmonary HMVECs. As a possible reason, fibroblasts exert their morphogenic activity at an early-phase, and then pulmonary endothelial cells might induce more differentiated bronchioalveolar structures. Because we did not observe expression of the ATI cell-specific protein AQP-5 in HBE135 cells, it would be interesting to verify whether HBE135 cell colonies with complex branching structures express AQP-5 when co-cultured with certain types of endothelial cells. However, VA10 cells form a complex branching structure in co-culture with HUVECs [18] . Although this discrepancy is not well understood, VA10 and HBE135 cells might be different cell types of the bronchiole or they might respond differently to the amount of HGF expressed by HUVECs.
After injury, lung stem cells must give rise to an appropriate number of differentiated progeny to achieve homoeostasis and restore the functional organ. The behaviour of epithelial stem cells is regulated by external signals from the microenvironment or niche in which stem cells reside. These signals include growth factors and other stem cell regulatory factors secreted by niche cells that can be a wide variety of differentiated cell types, including fibroblasts, smooth muscle cells, endothelial cells and neurons, as well as neighbouring stem cell progeny [24] . HBE135 cells did not form any colonies in a collagen gel and required rBM to form colonies. In addition, conditioned medium from cultures with preformed complex branching had some morphogenic effects, but there was little colony formation (1-3 colonies/50 ll rBM). Therefore, soluble factors are insufficient for HBE135 cells to form colonies and a certain number of cells are required for proliferation in 3D culture. A specific microenvironment, such as matrix constitutes and cell-cell interactions, is required for HBE135 cells to form colonies. We will in detail examine the microenvironment or niche for branching morphology of BEC cells. In contrast, RLE-6TN cells, a model of ATII cells, formed spherical colonies in rBM but did not exhibit the complex branching. It is noteworthy that, for the complex branching structure, tissue-specific stem cells were required in 3D culture. Some important and unresolved problems exist, such as the complex branching had the characteristics of stem cells. Some reports suggest that the stem cells are c-kitpositive cells or bronchioalveolar stem cells, which coexpress the Clara cell marker Clara Cell secretary protein (CCSP) and ATII cell marker SP-C in the lungs, especially involving repair/regeneration after respiratory damage [25, 26] . We analysed the immunofluorescence studies and observed these protein-positive cells at the rim of the branching structures (Fig. S3) , suggesting that they are a kind of stem cell. However, further studies are needed to draw a conclusion on this issue.
We provided evidence that HGF-Met signalling pathway was activated in neoplastic histogenesis of BECs as exemplified by lung adenocarcinoma. Among lung adenocarcinomas, intermediate to high levels of Met correlates with a greater degree of tumour differentiation [27] . Nakamura et al. immunohistochemically investigated HGF, Met and phospho-Met (Tyr1235) in resected lung adenocarcinomas [17] . They reported a significant association of phospho-Met expression with tumour differentiation but not the pathological stage, lymph node metastasis or survival. In particular, phospho-Met was correlated with papillary histology [17] . As a possible reason, Met activation may require cell-cell or cell-matrix adhesions, and thus may be less efficient in poorly differentiated tumours [28] . The HGF-Met system is involved in branching tubulogenesis of the lung [22] and other origins [28] . In the present study, we found that the HGF-Met pathway induces HBE135 cells into a highly morphogenic, bronchioalveolar structure in 3D culture. Therefore, the complex branching formation of HBE135 cells may be a useful model to analyse the effects of Met activation on the well-differentiated histogenesis of lung adenocarcinoma.
In conclusion, we presented a new 3D culture model to verify whether human BECs intrinsically have characteristics of pulmonary stem cells. In future studies, we intend to explore the more precise molecular mechanisms of bronchioalveolar morphogenesis and neoplastic histogenesis of human BECs by analysing this unique model with complex branching structures. Figure S1 Higher magnification of image for E-cadherin in the branching structure co-cultured with MRC-9 cells in Matrigel. White arrows indicate that the E-cadherin was stained stronger at cell-cell junctions; scale bars: 20 lm. (B) Immunoblot analysis shows phosphorylated Met (Tyr1234/1235), total Met and Actin protein levels. Lane 1 shows HBE135 cells treated with 10 ng/ml rHGF at 10 min., Lane 2 shows HBE135 cells treated with 10 ng/ml rHGF at 10 min. after pre-treatment with 10 ng/ml rHGF every 2 hrs (three times, total 6 hrs), and Lane 3 shows HBE135 cells treated with 10 ng/ml rHGF for 6 hrs. 
